<SEC-DOCUMENT>0001104659-20-048027-index.html : 20200417 <SEC-HEADER>0001104659-20-048027.hdr.sgml : 20200417 <ACCEPTANCE-DATETIME>20200417115416 ACCESSION NUMBER: 0001104659-20-048027 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 8 CONFORMED PERIOD OF REPORT: 20200417 FILED AS OF DATE: 20200417 DATE AS OF CHANGE: 20200417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ONCOLYTICS BIOTECH INC CENTRAL INDEX KEY: 0001129928 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38512 FILM NUMBER: 20798422 BUSINESS ADDRESS: STREET 1: 1167 KENSINGTON CRES NW SUITE 210 STREET 2: CALGARY ALBERTA CANADA T2N 1X7 CITY: ALBERTA CANADA STATE: A0 ZIP: 00000 BUSINESS PHONE: 4036707380 MAIL ADDRESS: STREET 1: 210 - 1167 KENSINGTON CRES NW CITY: CALGARY STATE: A0 ZIP: T2N 1X7 </SEC-HEADER> <DOCUMENT> <TYPE>6-K <SEQUENCE>1 <FILENAME>tm2016145d1_6k.htm <DESCRIPTION>FORM 6-K <TEXT> Document 1 - file: tm2016145d1_6k.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>2 <FILENAME>tm2016145-1_ex991.htm <DESCRIPTION>EXHIBIT 99.1 <TEXT> Document 2 - file: tm2016145-1_ex991.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>image_001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: image_001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>image_002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: image_002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>image_003.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: image_003.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>image_004.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: image_004.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>image_005.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: image_005.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>8 <FILENAME>image_006.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 8 - file: image_006.jpg
</DOCUMENT> </SEC-DOCUMENT>